they saw 30% stabilization in these end of life patients ..its proving itself in the trials. yet another indicator to go with all the others.its easy to see why talks are geared toward fastest way to market..hard to price a dramatically cheaper, more effective, and easily tolerated cancer treatment for current cancer types for which there is no treatment but adxs..